Navigation Links
A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
Date:12/14/2007

COLUMBIA, Md., Dec. 14 /PRNewswire/ -- A&G Pharmaceutical announced today that the Avon Foundation Breast Cancer Prevention Research Initiative has awarded A&G an $870,000 grant to conduct multicenter clinical studies focused on measuring levels of A&G's proprietary breast cancer biomarker, GP88, in blood and tissue samples from breast cancer patients. Results of the studies could provide the basis for developing a blood test that would enable early detection of breast cancer.

The award was one of 12 grants totaling more than $7 million awarded this year by the Avon Foundation as part of its Breast Cancer Prevention Research Initiative, and it is the first ever awarded by the foundation to a private company.

The GP88 blood diagnostic test is one of two breast cancer test kits in late-stage development by A&G. In addition to the blood test, A&G is developing a tissue biopsy test that would help pathologists and oncologists predict risk of recurrence in breast cancer patients. Both diagnostic tests are based on A&G's patented, proprietary GP88 growth factor, a protein found in circulating blood and tissue of breast cancer patients. Concurrently, A&G is developing a monoclonal antibody therapeutic that neutralizes the function of GP88 in breast cancer. The National Cancer Institute recently awarded A&G a $120,000 Phase I Small Business Innovation Research (SBIR) grant to support development of this new anti-GP88 therapeutic.

"Breast cancer is the most commonly diagnosed cancer in women-a projected 1.2 million new cases of breast cancer will be diagnosed this year-and early detection, when the disease is most treatable, continues to be a major worldwide challenge," said Carol Kurzig, Executive Director of the Avon Foundation. "We are very pleased to make this award to A&G Pharmaceutical, whose highly sensitive GP88 test has the potential to detect breast cancer cells at the earliest stage of the disease."

"We greatly appreciate Avon's
'/>"/>

SOURCE A&G Pharmaceutical
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... a leader in data visualization, today unveils a new ... hospital costs across the United States . The tool ... “Medicare Provider Charge Data,” a dataset of pricing information ... for Medicare & Medicaid Services. , The wide variation ... country has sparked considerable controversy; however, it is nearly ...
(Date:5/20/2013)... The World Molecular Imaging Society (WMIS) ... Baird as Executive Director. Baird will assume leadership ... The WMIS vision is to encompass and promote preclinical ... treat diseases in the developed and developing world. ... 2011 by integrating the Academy of Molecular Imaging and ...
(Date:5/19/2013)... The JM Internet Group (web: jm-seo.org), ... proudly announced that the company's YouTube channel on ... views on YouTube. The company uses YouTube as a ... and training for small businesses with much success. , ... tips helpful for their SEO strategies", explained Jason McDonald, ...
(Date:5/17/2013)... Dr. Sparano is Professor of Medicine ... the Albert Einstein College of Medicine and Associate Chairman ... Center. He is also Associate Director for Clinical ... Einstein Breast Cancer Working Group, a multidisciplinary group of ... He also serves as Vice Chair of the National ...
Breaking Biology Technology:Kitware Enables Interactive Exploration of CMS Medicare Data 2WMIS Appoints Lisa Baird as Next Executive Director 2YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 2Joseph A. Sparano, MD, Named Vice Chair of ECOG-ACRIN Cancer Research Group 3
... - Global Advocacy Groups Launch Joint Effort to ... new international survey reveal that eye exams are being,ignored by ... visited an,eye specialist in the last year to have their ... compared to heart disease or early,death. The survey showed that ...
... the sabre-toothed cat Smilodon ranks alongside Tyrannosaurus rex as ... like knives, Smilodon was a fearsome predator of Ice-Age ... years, scientists have debated how this iconic predator used ... new Australian study, published today in the US Proceedings ...
... today that,the company,s Carlsbad, CA, CLIA laboratory operation ... The laboratory offers,two new molecular oncology tests to ... ID(TM) is a 92-gene expression assay capable of ... molecular classification of metastatic,cancer and guides the physician ...
Cached Biology Technology:International Survey Shows People Over Forty Ignore Risk of Blindness 2International Survey Shows People Over Forty Ignore Risk of Blindness 3International Survey Shows People Over Forty Ignore Risk of Blindness 4International Survey Shows People Over Forty Ignore Risk of Blindness 5Scientists say sabercat bit like a pussycat 2AviaraDx Announces CAP Accreditation of Its Laboratory Operations 2
(Date:5/20/2013)... colistin are also commonly resistant to antimicrobial substances ... study in mBio , the online open-access ... to colistin and host antimicrobials LL-37 and lysozyme, ... could mean that patients with life-threatening multi-drug resistant ... response. Colistin is a last-line drug for treating ...
(Date:5/20/2013)... - A National Science Foundation (NSF) planning grant will ... (CARD), a joint program of the University of Illinois ... Mass. , "CARD will be devoted to research in ... agricultural products; forestry and paper products; chemical products; textiles; ... professor of food science and human nutrition and the ...
(Date:5/19/2013)... that can grow using hydrogen gas as its sole ... of carbon. Researchers at the University of Massachusetts, ... of the American Society for Microbiology. , "This represents ... says Amit Kumar, a researcher on the study who, ... Lab Group at the university. , Under the leadership ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
... Johns Hopkins scientists have discovered that a deceptively simple ... natural life cycle. , The discovery reveals that, when ... diseases by failing to properly control the steps and ... are described in the Sept. 23 issue of the ...
... be an early step in the development of sporadic colorectal ... may ultimately be useful in risk assessment for colorectal cancer, ... of the Journal of the National Cancer Institute. ... a "field defect", cells that appear normal but that have ...
... may be mass produced at a lower cost, ... compositions than ever before, for dramatic improvements in ... structures. These entirely new biologically-enabled approaches are detailed ... of Applied Ceramic Technology, published on behalf of ...
Cached Biology News:Sugar helps control cell division 2Sugar helps control cell division 3Change in gene may be underlying molecular defect in some colorectal cancers 2
For cleavage of 6xHis tags from proteins containing a Factor Xa Protease recognition site Efficient 6xHis tag cleavage (greater than 90%), ...
... PBL's bioassays for interferons are cytopathic effect inhibition ... Sample types include; tissue culture supernatents; serum ... these assays, one unit is defined as the ... the cytopathic effect of viral infection by 50%. ...
... effect inhibition assays, also known as CPE and ... supernatents; serum from PK studies and delivery formulations. ... as the quantity of interferon required per milliliter ... by 50%. All standards used in ...
... effect inhibition assays, also known as CPE and ... supernatents; serum from PK studies and delivery formulations. ... as the quantity of interferon required per milliliter ... by 50%. All standards used in ...
Biology Products: